Compared with the non-statin group, patients in the statin group were older, had lower heart rates, high systolic blood pressure and SPO2, lower lactate levels but higher cTnT and PLT levels, lower prevalence of cirrhosis, higher prevalence of diabetes mellitus and other chronic comorbidities (Atrial Fibrillation, hyperlipidemia), and lower SOFA, SAPS II, and LODS scores. The gene discussed is TNNT2; the disease is hyperlipidemia.